For HIV infection that has not previously been treated, the United States Department of Health and Human Services Panel on Antiretroviral Guidelines recommends the use of<unk>  in combination with tenofovir/emtricitabine (Truvada) as one of the preferred NNRTI-based regimens in adults and adolescents and children.<unk>  is also used in combination with other antiretroviral agents as part of an expanded post-exposure prophylaxis regimen to reduce the risk of HIV infection in people exposed to a significant risk (e.g. needlestick injuries, certain types of unprotected sex, etc.). Pregnancy and breastfeeding<unk>  is safe to use during the first trimester of pregnancy.<unk>  passes into breast milk and breast-fed infants may be exposed to<unk> .
Efavirenz
Saquinavir
Zidovudine
Lamivudine
Entecavir
Amprenavir
Fosamprenavir
Telbivudine